SCHEMBL6558710

SCHEMBL6558710

CCS(=O)(=O)N(CC1CC1)C1CC(C)(C)Oc2ccc(C(=O)OC)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 3/20 0.33
CNR2 P34972 3/20 0.33
TSHR P16473 2/20 0.33
RAB9A P51151 2/20 0.33
LMNA P02545 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KCNE1 P15382 3/20 0.33
KCNQ1 P51787 3/20 0.33
OPRD1 P41143 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559205 0.91 SMN1; SMN2 (0.38) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6558561 0.89 KCNE1 (0.34) KCNA5MEN1KMT2ACYP1A2CYP2C19
SCHEMBL6559952 0.87 KCNA5 (0.41) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6560813 0.85 KCNE1 (0.42) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6559604 0.84 MEN1 (0.36) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6559403 0.83 KCNA5 (0.37) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL7830067 0.83 KCNE1 (0.37) KCNA5MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6559333 0.81 KCNE1 (0.44) KCNA5MEN1KMT2ACNR2CYP1A2
SCHEMBL6558072 0.80 SIRT2 (0.33) MEN1KMT2ACYP1A2CYP2C19KCNE1
SCHEMBL6559500 0.79 NPSR1 (0.38) KCNA5MEN1KMT2ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed